Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241210245 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ekaterina P Kolesova und 13 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Center for Translation Medicine, Sirius University of Science and Technology, 354340 Sochi, Russia. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Proteolytic activity is pivotal in maintaining cell homeostasis and function. In pathological conditions such as cancer, it covers a key role in tumor cell viability, spreading to distant organs, and response to the treatment. Endosomes represent one of the major sites of cellular proteolytic activity and very often represent the final destination of internalized nanoformulations. However, little information about nanoparticle impact on the biology of these organelles is available even though they represent the major location of drug release. In this work, we generated albumin nanoparticles with a different resistance to proteolysis by finely tuning the amount of cross-linker used to stabilize the carriers. After careful characterization of the particles and measurement of their degradation in proteolytic conditions, we determined a relationship between their sensitivity to proteases and their drug delivery properties. These phenomena were characterized by an overall increase in the expression of cathepsin proteases regardless of the different sensitivity of the particles to proteolytic degradation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Scientific Center for Translation Medicine, Sirius University of Science and Technology, 354340 Sochi, Russia.
- Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
- Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
- Department of Biomedical Engineering, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
- Federal Scientific Research Center "Crystallography and Photonics", Russian Academy of Sciences, 119333 Moscow, Russia.
- School of Physics, ITMO University, Lomonosova 9, 191002 St. Petersburg, Russia.
ORCID-Profile: Ekaterina P Kolesova, Anastasiia S Frolova, Dmitry Kostyushev, Sergey Brezgin, Daria B Trushina, Mikhail Zyuzin, Polina A Demina, Evgeny V Khaydukov, Andrey A Zamyatnin, Alessandro Parodi
Förderung
- Russian Science Foundation
Zitieren
APA
Kolesova, E. P., Egorova, V. S., Syrocheva, A. O., Frolova, A. S., Kostyushev, D., Kostyusheva, A., Brezgin, S., Trushina, D. B., Fatkhutdinova, L., Zyuzin, M., Demina, P. A., Khaydukov, E. V., Zamyatnin, A. A., & Parodi, A. (2023). Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241210245
Vancouver
Kolesova EP, Egorova VS, Syrocheva AO, Frolova AS, Kostyushev D, Kostyusheva A, et al. Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241210245
BibTeX
@article{Kolesova2023,
author = {Kolesova, Ekaterina P and Egorova, Vera S and Syrocheva, Anastasiia O and Frolova, Anastasiia S and Kostyushev, Dmitry and Kostyusheva, Anastasiia and Brezgin, Sergey and Trushina, Daria B and Fatkhutdinova, Landysh and Zyuzin, Mikhail and Demina, Polina A and Khaydukov, Evgeny V and Zamyatnin, Andrey A and Parodi, Alessandro},
title = {Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241210245}
}
EUVIMED